Clinical Trials Browser

Completed × INDUSTRY × oblimersen × Clear all

NCT00636545 2012-04-06

Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00518895 2011-11-07

AGENDA

Phase 3 Completed

Melanoma, Skin Neoplasms

NCT00543231 2007-10-12

A Phase I Study of G3139 Subcutaneous in Solid Tumors

Phase 1 Completed

Neoplasms